Skip to Content

S 707 (Topiramate 25 mg)

Pill imprint S 707 has been identified as Topiramate 25 mg.

Topiramate is used in the treatment of obesity; migraine prevention; fibromyalgia; vulvodynia; bipolar disorder (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Topiramate 25 mg S 707 Front
Topiramate 25 mg S 707 Back
Topiramate 25 mg S 707
Topiramate 25 mg S 707 Front
Topiramate 25 mg S 707 Back
S 707
25 mg
6.00 mm
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Sun Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
microcrystalline cellulose
corn starch
sodium starch glycolate type A potato
magnesium stearate
polyvinyl alcohol
titanium dioxide
polyethylene glycol
magnesium silicate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
47335-0707 Sun Pharmaceutical Industries Inc.
54868-6016 Physicians Total Care Inc (repackager)
21695-0162 Rebel Distributors Corp (repackager)
68258-3000 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.